90Y-FAPI-04

N/A

Report date: 2025/10/20 14:27:15

NME

Base Information

Drug Name90Y-FAPI-04

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Yttrium > 90YRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionFibroblast activation protein alpha inhibitors

TargetsProlyl endopeptidase FAP

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesHeidelberg University Hospital

China Registration ClassN/A

Develop Information

Active CompaniesHeidelberg University Hospital

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A